Table 3

Prevalence of breast cancer risk factors in non-Hispanic white women 35 to 74 years of age

Patient characteristics

Population-based control series (1989–1999)

California Health Interview Survey


SFBA

(n = 1,168)

2001

2003


SFBA

Californiaa

SFBA

Californiaa


Education

Some high school or less

3.2 (2.2–4.2)

2.3 (1.2–3.3)

7.5 (6.7–8.3)

2.9 (1.5–4.4)

6.2 (5.4–7.0)

High school graduate

20.7 (17.9–23.4)

18.1 (16.0–20.2)

23.3 (22.4–24.3)

15.4 (13.3–17.5)

23.8 (22.6–25.0)

Some college

27.7 (24.5–30.9)

27.0 (24.6–29.3)

34.4 (33.3–35.5)

25.1 (22.6–27.7)

34.3 (33.1–35.6)

College graduate or higher

46.7 (42.5–50.9)

52.7 (50.0–55.3)

34.8 (33.7–35.9)

56.5 (53.6–59.4)

35.6 (34.3–36.9)

Missing

1.6

Body mass index <25 in women <50 years

64.4 (56.6–72.1)

64.1 (60.4–67.7)

58.0 (56.2–59.7)

63.9 (59.7–68.1)

57.2 (55.1–59.3)

Body mass index ≥ 30 in women ≥ 50 years

20.9 (17.5–24.2)

21.7 (18.5–24.8)

21.5 (20.2–22.9)

21.1 (17.7–24.5)

22.9 (21.4–24.4)

History of breast cancer in mother, sister, or daughter

13.9 (11.6–16.1)

b

b

b

b

Ever had a breast biopsy that was not cancer

11.7 (9.8–13.5)

b

b

b

b

Ever had radiation treatment to the chest

2.0 (1.2–2.7)

b

b

b

b

No vigorous/moderate physical activity in past 30 days

b

19.8 (17.7–22.0)

23.4 (22.4–24.4)

b

b

Drank alcohol in past month

b

71.3 (68.9–73.8)

61.3 (60.1–62.4)

69.8 (67.0–72.7)

61.0 (59.7–62.3)

2+ drinks per dayc

27.6

23.6

28.0

25.9

Age at menarche <12 years

21.0 (18.2–23.8)

18.5 (16.4–20.6)

19.4 (18.5–20.4)

b

b

Age at first live birth ≥ 30 years

20.7 (17.8–23.7)

20.4 (18.3–22.5)

13.4 (12.6–14.2)

b

b

Number of live births

0

25.0 (21.9–28.1)

25.3 (23.2–27.4)

17.3 (16.5–18.2)

b

b

1–2

48.2 (43.9–52.6)

51.4 (48.7–54.0)

48.0 (46.8–49.2)

≥3

26.7 (23.8–29.7)

23.3 (21.0–25.6)

34.7 (33.6–35.8)

Hormone therapy use

Never

53.7 (48.8–58.5)

b

b

b

b

<5 years

21.2 (18.6–23.8)

≥5 years

22.8 (20.3–25.3)

Missing

2.3

Ever took hormone supplements for menopause symptoms

b

b

b

29.8 (26.7–33.0)

34.5 (32.9–36.0)

Currently takes hormone supplements for menopause symptoms

b

34.9 (32.1–37.7)

37.0 (35.8–38.2)

16.7 (14.2–19.1)

21.6 (20.4–22.7)

Among women without a hysterectomyd

20.4

18.7

4.9

5.2

Mammogram screening history

2 years or less

b

72.9 (70.5–75.2)

70.4 (69.3–71.5)

71.0 (68.3–73.7)

71.6 (70.3–72.8)

More than 2 years ago

12.1 (10.4–13.8)

13.7 (12.9–14.5)

12.9 (10.9–14.9)

13.4 (12.5–14.3)

Never had a mammogram

15.1 (13.1–17.0)

15.9 (15.0–16.8)

16.1 (13.8–18.3)

15.0 (14.0–16.1)


aExcluding the SFBA. bNot available in the population-based control series or AskCHIS. cCalculated by dividing the number of women drinking 2+ drinks per day in the past 30 days by the total number of women (that is, the number of women who did and did not drink alcohol in the past 30 days). dCalculated by dividing the number of women who did not have a hysterectomy and reported using hormone supplements by the total number of women (that is, the number of women who did and did not take hormone supplements for menopause symptoms). SFBA, San Francisco Bay area.

Keegan et al. Breast Cancer Research 2007 9:R62   doi:10.1186/bcr1768

Open Data